ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
ANI Pharmaceuticals (NASDAQ: ANIP) has announced that CEO Nikhil Lalwani will present at the upcoming 2025 Jefferies Global Healthcare Conference in New York City. The presentation is scheduled for Wednesday, June 4, 2025, at 2:35 PM ET.
Investors can access the live and archived webcast through ANI Pharmaceuticals' website at www.anipharmaceuticals.com in the Investors section under Events and Presentations. The webcast replay will be available for 60 days after the event. Interested parties can schedule one-on-one meetings with the company by contacting their Jefferies representative.
ANI Pharmaceuticals (NASDAQ: ANIP) ha annunciato che l'Amministratore Delegato Nikhil Lalwani presenterà alla 2025 Jefferies Global Healthcare Conference che si terrà a New York. La presentazione è prevista per mercoledì 4 giugno 2025, alle 14:35 ET.
Gli investitori potranno seguire la diretta e rivedere la registrazione del webcast sul sito web di ANI Pharmaceuticals, www.anipharmaceuticals.com, nella sezione Investors, sotto Eventi e Presentazioni. La registrazione sarà disponibile per 60 giorni dopo l'evento. Chi fosse interessato può fissare incontri individuali con la società contattando il proprio rappresentante Jefferies.
ANI Pharmaceuticals (NASDAQ: ANIP) ha anunciado que el CEO Nikhil Lalwani presentará en la próxima Conferencia Global de Salud Jefferies 2025 en la ciudad de Nueva York. La presentación está programada para el miércoles 4 de junio de 2025 a las 2:35 PM ET.
Los inversores pueden acceder a la transmisión en vivo y a la repetición archivada a través del sitio web de ANI Pharmaceuticals, www.anipharmaceuticals.com, en la sección de Inversores bajo Eventos y Presentaciones. La repetición del webcast estará disponible durante 60 días después del evento. Las partes interesadas pueden programar reuniones individuales con la empresa contactando a su representante de Jefferies.
ANI Pharmaceuticals (NASDAQ: ANIP)는 CEO 니킬 랄와니가 뉴욕에서 열리는 2025 Jefferies 글로벌 헬스케어 컨퍼런스에서 발표할 예정이라고 발표했습니다. 발표 일정은 2025년 6월 4일 수요일 오후 2시 35분(동부시간)입니다.
투자자들은 ANI Pharmaceuticals 웹사이트 www.anipharmaceuticals.com의 투자자 섹션 내 이벤트 및 프레젠테이션에서 생중계 및 녹화된 웹캐스트를 시청할 수 있습니다. 웹캐스트 재생은 행사 후 60일 동안 제공됩니다. 관심 있는 분들은 제퍼리스 담당자를 통해 1:1 미팅을 예약할 수 있습니다.
ANI Pharmaceuticals (NASDAQ : ANIP) a annoncé que le PDG Nikhil Lalwani présentera lors de la 2025 Jefferies Global Healthcare Conference à New York. La présentation est prévue pour le mercredi 4 juin 2025 à 14h35 ET.
Les investisseurs peuvent accéder à la diffusion en direct et au replay via le site web d'ANI Pharmaceuticals à l'adresse www.anipharmaceuticals.com, dans la section Investisseurs sous Événements et Présentations. Le replay du webcast sera disponible pendant 60 jours après l'événement. Les personnes intéressées peuvent organiser des réunions individuelles avec la société en contactant leur représentant Jefferies.
ANI Pharmaceuticals (NASDAQ: ANIP) hat bekanntgegeben, dass CEO Nikhil Lalwani auf der bevorstehenden 2025 Jefferies Global Healthcare Conference in New York City präsentieren wird. Die Präsentation ist für Mittwoch, den 4. Juni 2025, um 14:35 Uhr ET geplant.
Investoren können den Live-Stream sowie die Aufzeichnung über die Website von ANI Pharmaceuticals unter www.anipharmaceuticals.com im Bereich Investoren unter Veranstaltungen und Präsentationen abrufen. Die Wiedergabe des Webcasts ist 60 Tage nach der Veranstaltung verfügbar. Interessenten können Einzelgespräche mit dem Unternehmen über ihren Jefferies-Ansprechpartner vereinbaren.
- None.
- None.
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows:
| Date: | Wednesday, June 4, 2025 |
| Time: | 2:35pm ET |
| Webcast: | Click Here |
To schedule a 1x1 meeting with the Company, please contact your Jefferies representative at healthcareconference@jefferies.com.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 60 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the 2025 Jefferies Healthcare Conference?
How can investors watch ANI Pharmaceuticals' (ANIP) Jefferies conference presentation?
Who will represent ANI Pharmaceuticals (ANIP) at the 2025 Jefferies Healthcare Conference?
How can investors schedule meetings with ANI Pharmaceuticals (ANIP) at the Jefferies conference?
